Wells Fargo’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-65,067
| Closed | -$222K | – | 6205 |
|
|
2018
Q3 | $222K | Buy |
65,067
+4,396
| +7% | +$15K | ﹤0.01% | 4781 |
|
|
2018
Q2 | $228K | Sell |
60,671
-546
| -0.9% | -$2.05K | ﹤0.01% | 4796 |
|
|
2018
Q1 | $250K | Buy |
61,217
+3,427
| +6% | +$14K | ﹤0.01% | 4691 |
|
|
2017
Q4 | $269K | Sell |
57,790
-25,026
| -30% | -$116K | ﹤0.01% | 4663 |
|
|
2017
Q3 | $588K | Buy |
82,816
+5,640
| +7% | +$40K | ﹤0.01% | 4132 |
|
|
2017
Q2 | $558K | Buy |
77,176
+3,250
| +4% | +$23.5K | ﹤0.01% | 4060 |
|
|
2017
Q1 | $455K | Buy |
73,926
+12,987
| +21% | +$79.9K | ﹤0.01% | 4205 |
|
|
2016
Q4 | $358K | Buy |
60,939
+25,398
| +71% | +$149K | ﹤0.01% | 4287 |
|
|
2016
Q3 | $188K | Sell |
35,541
-4,241
| -11% | -$22.4K | ﹤0.01% | 4347 |
|
|
2016
Q2 | $264K | Sell |
39,782
-2,180
| -5% | -$14.5K | ﹤0.01% | 4128 |
|
|
2016
Q1 | $196K | Buy |
41,962
+1,443
| +4% | +$6.74K | ﹤0.01% | 4285 |
|
|
2015
Q4 | $205K | Buy |
40,519
+947
| +2% | +$4.79K | ﹤0.01% | 4296 |
|
|
2015
Q3 | $139K | Sell |
39,572
-53,235
| -57% | -$187K | ﹤0.01% | 4519 |
|
|
2015
Q2 | $926K | Buy |
92,807
+26,688
| +40% | +$266K | ﹤0.01% | 3615 |
|
|
2015
Q1 | $842K | Buy |
66,119
+9,914
| +18% | +$126K | ﹤0.01% | 3574 |
|
|
2014
Q4 | $796K | Sell |
56,205
-62,283
| -53% | -$882K | ﹤0.01% | 3589 |
|
|
2014
Q3 | $1.63M | Buy |
118,488
+891
| +0.8% | +$12.3K | ﹤0.01% | 3093 |
|
|
2014
Q2 | $1.81M | Sell |
117,597
-2,723,326
| -96% | -$41.9M | ﹤0.01% | 3040 |
|
|
2014
Q1 | $48.4M | Buy |
2,840,923
+1,201,758
| +73% | +$20.5M | 0.02% | 774 |
|
|
2013
Q4 | $21.2M | Buy |
1,639,165
+1,626,028
| +12,377% | +$21.1M | 0.01% | 1207 |
|
|
2013
Q3 | $132K | Sell |
13,137
-4,463
| -25% | -$44.8K | ﹤0.01% | 4335 |
|
|
2013
Q2 | $131K | Buy |
+17,600
| New | +$131K | ﹤0.01% | 4263 |
|